海角直播

Alembic Pharmaceuticals Receives EIR from US FDA for Oncology Formulation Facility

Naman Bansal April 30, 2025 PR

30 April 2025, Bengaluru: Alembic Pharmaceuticals Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Oncology Formulation Facility (Injectable and Oral Solid), located at Panelav.

This follows the successful completion of a US FDA inspection conducted at the facility from October 7 to October 8, 2024, as communicated in earlier intimation.

The receipt of the EIR signifies the closure of the inspection process and reinforces Alembic海角直播 commitment to global regulatory compliance and high-quality manufacturing standards.

Check Also

Kotak Education Foundation Unveils Kotak Junior Scholarship 鈥淔uture Ka Golden Ticket鈥 鈥 1,000 Scholarships for Class 10+ Students in Mumbai.

Empowering bright young minds with 鈧73,500 in financial aid, mentorship, and holistic from economically disadvantaged …

Copyright 漏 2024, 海角直播